New York, NYCIK 780034 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
18 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Oric Pharmaceuticals Inc | 5.38M | $43.98M | 18.6% | 0 | Held |
| 2 | Arvinas Inc | 3.46M | $41.01M | 17.3% | 0 | Held |
| 3 | Celcuity Inc | 349.4K | $34.85M | 14.7% | 0 | Held |
| 4 | Wave Life Sciences Ltd |
| 1.88M |
| $31.88M |
| 13.5% |
| 0 |
| Held |
| 5 | Allogene Therapeutics Inc | 22.03M | $30.18M | 12.8% | 0 | Held |
| 6 | Zura Bio Ltd | 2.97M | $15.56M | 6.6% | 0 | Held |
| 7 | Pyxis Oncology Inc | 7.03M | $8.09M | 3.4% | 0 | Held |
| 8 | Caribou Biosciences Inc | 4.69M | $7.46M | 3.2% | 0 | Held |
| 9 | Cardiff Oncology Inc | 2.41M | $6.78M | 2.9% | 0 | Held |
| 10 | Biohaven Ltd | 505.6K | $5.71M | 2.4% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio